seed
Stage
3
Investors
About
Sincrolab offers a CE-marked digital therapeutic app providing a personalized 6-month program for children with attention difficulties (ADHD), combining daily gamified training with professional remote monitoring and evaluations to improve attention, organization, and family well-being from home.
Explore Sincrolab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.